title: A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients.
abstract: OBJECTIVE
  This paper describes the outcome for the first 148 patients referred to a lithium clinic.
  
  
  METHODS
  Two-year follow-up data from treatment charts are reported for all patients entering a lithium clinic in the study period.
  
  
  RESULTS
  Lithium was given as the only mood stabilizer in 132 (89.2%) of the cases. Thirty-two (21.6%) patients were readmitted with a new affective disorder episode. Twenty-nine (19.6%) patients discontinued treatment prematurely. Variables predicting the recurrence of new affective disorder episodes as well as premature discontinuation of treatment were identified.
  
  
  CONCLUSIONS
  The majority of bipolar patients received lithium for prophylaxis against recurrent affective disorder episodes. The outcome was moderate but comparable to the 30-40% improvement usually reported in follow-up studies of bipolar patients given long-term prophylactic treatment with lithium. Better long-term treatment results for bipolar patients depend on both the development of more effective mood stabilizing drugs or drug combinations and the improvement of patients' adherence to treatment.
authors.affiliation: Mood Disorders Research Unit, Aarhus University Psychiatric Hospital, Skovagervej 2, DK-8240 Risskov, Denmark.
authors.forename: R W
authors.initials: RW
authors.lastname: Licht
authors.forename: P
authors.initials: P
authors.lastname: Vestergaard
authors.forename: N A
authors.initials: NA
authors.lastname: Rasmussen
authors.forename: K
authors.initials: K
authors.lastname: Jepsen
authors.forename: A
authors.initials: A
authors.lastname: Brodersen
authors.forename: P E
authors.initials: PE
authors.lastname: Hansen
mesh_terms: D000328:Adult; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003718:Denmark; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010343:Patient Admission; D010359:Patient Readmission; D011569:Psychiatric Status Rating Scales; D012008:Recurrence; D012017:Referral and Consultation; D016896:Treatment Outcome
chemical_list: D018692:Antimanic Agents; D016651:Lithium Carbonate